Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/26/21 17:47 | 2/24/21 | AYLA | Health | BioPrd | Biological Products, (No Diag | Gordon Gary B. | L3 | O | Chief Me | S.d | -52 | 17.46 | 0 | -3 | -26 | 9 | D | ||||||||||||||
2/24/21 17:42 | 2/22/21 | AYLA | Health | BioPrd | Biological Products, (No Diag | Mamluk Roni | L3 | DO | P,CEO | S.m | -617 | 18.63 | 0 | -33 | -19 | 145 | D | ||||||||||||||
1/22/21 16:05 | 1/20/21 | AYLA | Health | BioPrd | Biological Products, (No Diag | Mamluk Roni | L3 | DO | P,CEO | S.m | -314 | 15.03 | 0 | -21 | -10 | 178 | D | ||||||||||||||
1/22/21 16:05 | 1/20/21 | AYLA | Health | BioPrd | Biological Products, (No Diag | Gordon Gary B. | L3 | O | Chief Me | S.d | -45 | 15.03 | 0 | -3 | -26 | 9 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |